- Home
- SPCB vs MIRA Comparison
SPCB vs MIRA Comparison
Compare SPCB & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPCB
- MIRA
- Stock Information
- Founded
- SPCB 1988
- MIRA 2020
- Country
- SPCB Israel
- MIRA United States
- Employees
- SPCB N/A
- MIRA N/A
- Industry
- SPCB Semiconductors
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- SPCB Technology
- MIRA Health Care
- Exchange
- SPCB Nasdaq
- MIRA Nasdaq
- Market Cap
- SPCB 24.7M
- MIRA 20.5M
- IPO Year
- SPCB N/A
- MIRA 2023
- Fundamental
- Price
- SPCB $6.65
- MIRA $1.00
- Analyst Decision
- SPCB Strong Buy
- MIRA Strong Buy
- Analyst Count
- SPCB 1
- MIRA 2
- Target Price
- SPCB $18.00
- MIRA $14.00
- AVG Volume (30 Days)
- SPCB 108.0K
- MIRA 359.3K
- Earning Date
- SPCB 05-14-2025
- MIRA 05-12-2025
- Dividend Yield
- SPCB N/A
- MIRA N/A
- EPS Growth
- SPCB N/A
- MIRA N/A
- EPS
- SPCB 1.02
- MIRA N/A
- Revenue
- SPCB $26,843,000.00
- MIRA N/A
- Revenue This Year
- SPCB $6.72
- MIRA N/A
- Revenue Next Year
- SPCB $16.91
- MIRA N/A
- P/E Ratio
- SPCB $6.53
- MIRA N/A
- Revenue Growth
- SPCB 5.23
- MIRA N/A
- 52 Week Low
- SPCB $2.55
- MIRA $0.51
- 52 Week High
- SPCB $18.95
- MIRA $5.01
- Technical
- Relative Strength Index (RSI)
- SPCB 41.26
- MIRA 38.63
- Support Level
- SPCB $6.35
- MIRA $0.95
- Resistance Level
- SPCB $7.33
- MIRA $1.29
- Average True Range (ATR)
- SPCB 0.54
- MIRA 0.10
- MACD
- SPCB 0.05
- MIRA -0.02
- Stochastic Oscillator
- SPCB 28.28
- MIRA 1.56
About SPCB SuperCom Ltd. (Israel)
SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT and Connectivity, which is the key revenue driver; and Cyber Security. Besides, it also offers a wide range of solutions that include national ID registries, e-passports, biometric visas, automated fingerprint identification systems, digitized driver's licenses, and electronic voter registration and election management using the common platform. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and the Asia Pacific.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.